Resting heart rate and relation to disease and longevity: past, present and future

References

• Saba MM, Ventura HO, Saleh M, et al. Ancient Egyptian medicine and the concept of heart failure. J Card Fail. 2006;12:416–421.
   PubMed Web of Science ®Google Scholar
• Ghasemzadeh N, Zafari AM. A brief journey into the history of the arterial pulse. Cardiol Res Pract. 2011;2011:164832.
   PubMedGoogle Scholar
• Bedford DE. The ancient art of feeling the pulse. Br Heart J. 1951;13:423–437.
   PubMedGoogle Scholar
• Vlachopoulos C, O'rourke M. Genesis of the normal and abnormal arterial pulse. Curr Probl Cardiol. 2000;25:303–367.
   PubMed Web of Science ®Google Scholar
• DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 1993;55:455–472.
   PubMed Web of Science ®Google Scholar
• DiFrancesco D, Borer JS. The funny current. Cellular basis for the control of heart rate. Drugs. 2007;67: 15–24.
   PubMed Web of Science ®Google Scholar
• Berne & Levy. Physiology. 4th edn. Mosby; 1998. Elsevier, The Netherlands.
   Google Scholar
• Purves D, Augustine GJ, Fitzpatrick D, et al. Autonomic Regulation of Cardiovascular Function. 2001; [cited 2016 Nov 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11075/
   Google Scholar
• Yasuma F, Hayano J-I. Respiratory sinus arrhythmia: why does the heartbeat synchronize with respiratory rhythm? Chest. 2004;125:683–690.
   PubMed Web of Science ®Google Scholar
• Barbieri R, Triedman JK, Saul JP. Heart rate control and mechanical cardiopulmonary coupling to assess central volume: a systems analysis. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1210–R1220.
   PubMed Web of Science ®Google Scholar
• Bainbridge FA. The influence of venous filling upon the rate of the heart. J Physiol (Lond). 1915;50:65–84.
   Google Scholar
• Levine H. Rest heart rate and life expectancy. J Am Coll Cardiol. 1997;1104–1106.
   PubMed Web of Science ®Google Scholar
• Noujaim SF, Lucca E, Muñoz V, et al. From mouse to whale: a universal scaling relation for the PR interval of the electrocardiogram of mammals. Circulation. 2004;110:2802–2808.
   PubMed Web of Science ®Google Scholar
• Azbel MY. Universal biological scaling and mortality. Proc Natl Acad Sci USA. 1994;91:12453–12457.
   PubMed Web of Science ®Google Scholar
• Coburn AF, Grey RM, Rivera SM. Observations on the relation of heart rate, life span, weight and mineralization in the digoxin-treated A-J mouse. Johns Hopkins Med J. 1971;128:169–193.
   PubMedGoogle Scholar
• Gent S, Kleinbongard P, Dammann P, et al. Heart rate reduction and longevity in mice. Basic Res Cardiol. 2015;110:2.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Allin KH, et al. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol. 2012;19:102–108.
   PubMed Web of Science ®Google Scholar
• Colman RJ, Beasley TM, Kemnitz JW, et al. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun. 2014;5:3557.
   PubMed Web of Science ®Google Scholar
• Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 1984;226:180–182.
   PubMed Web of Science ®Google Scholar
• Kaplan JR, Manuck SB, Adams MR, et al. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 1987;76:1364–1372.
   PubMed Web of Science ®Google Scholar
• Reil J-C, Hohl M, Reil G-H, et al. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J. 2013;34:2839–2849.
   PubMed Web of Science ®Google Scholar
• Libby B, Zipes M. Braunwald’s Heart Disease. A textbook of cardiovascular medicine. Saunders. 2008. Elsevier, The Netherlands.
   Google Scholar
• Ostchega Y, Porter KS, Hughes J, et al. Resting pulse rate reference data for children, adolescents, and adults: United States, 1999–2008. Natl Health Stat Rep. 2011;41:1–16.
   Google Scholar
• Jensen MT, Wod M, Galatius S, et al. Heritability of resting heart rate and association with mortality in middle-aged and elderly twins. Heart Br Card Soc. 2017;104:30–36.
   Google Scholar
• Khera R, Lu Y, Saxena A, et al. The impact of 2017 ACC/AHA guidelines on the prevalence of hypertension and eligibility for anti-hypertensive therapy in the United States and China: Nationally representative cross sectional study. Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, Krumholz HM. BMJ. 2018;11:362:k2357. doi:10.1136/bmj.k2357. PMID:29997129
   Google Scholar
• Inoue T, Iseki K, Iseki C, et al. Elevated resting heart rate is associated with white blood cell count in middle-aged and elderly individuals without apparent cardiovascular disease. Angiology. 2012;63:541–546.
   PubMed Web of Science ®Google Scholar
• Sajadieh A, Nielsen O, Rasmussen V, et al. Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2004;25:363–370.
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25:1–72.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Suadicani P, Hein HO, et al. Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study. Heart Br Heart. 2013;99:882–887.
   PubMed Web of Science ®Google Scholar
• Rennie KL, Hemingway H, Kumari M, et al. Effects of moderate and vigorous physical activity on heart rate variability in a British study of civil servants. Am. J. Epidemiol. 2003;158:135–143.
   PubMed Web of Science ®Google Scholar
• Aladin AI, Whelton SP, Al-Mallah MH, et al. Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford Exercise Testing Project). Am. J. Cardiol. 2014;114:1701–1706.
   PubMed Web of Science ®Google Scholar
• den Hoed M, Eijgelsheim M, Esko T, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45:621–631.
   PubMed Web of Science ®Google Scholar
• Eppinga RN, Hagemeijer Y, Burgess S, et al. Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality. Nat Genet. 2016;48:1557–1563.
   PubMed Web of Science ®Google Scholar
• Havlik RJ, Garrison RJ, Fabsitz R, et al. Variability of heart rate, P-R, QRS and Q-T durations in twins. J Electrocardiol. 1980;13:45–48.
   PubMed Web of Science ®Google Scholar
• Van Hulle CA, Corley R, Zahn-Waxler C, et al. An exploration of the genetic and environmental etiology of heart rate in infancy and middle childhood. Twin Res. 2000;3:259–265.
   PubMedGoogle Scholar
• Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–749.
   PubMed Web of Science ®Google Scholar
• Greenland P, Daviglus ML, Dyer AR, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1999;149:853–862.
   PubMed Web of Science ®Google Scholar
• Hsia J, Larson JC, Ockene JK, et al. Group for the WHIR. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ. 2009;338:b219.
   PubMed Web of Science ®Google Scholar
• Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2015;188:E53–63.
   PubMed Web of Science ®Google Scholar
• Shaper AG, Wannamethee G, Macfarlane PW, et al. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J. 1993;70:49–55.
   PubMedGoogle Scholar
• Kannel WB, Kannel C, Paffenbarger RS, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113:1489–1494.
   PubMed Web of Science ®Google Scholar
• Jouven X, Empana JP, Escolano S, et al. Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol. 2009;103:279–283.
   PubMed Web of Science ®Google Scholar
• Custodis F, Roggenbuck U, Lehmann N, et al. Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population. Clin Res Cardiol. 2016;105:601–612.
   PubMed Web of Science ®Google Scholar
• Kristal-Boneh E, Silber H, Harari G, et al. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male israeli employees (the CORDIS Study). Eur Heart J. 2000;21:116–124.
   PubMed Web of Science ®Google Scholar
• Fujiura Y, Adachi H, Tsuruta M, RJD, et al. Heart rate and mortality in a Japanese general population: An 18-year follow-up study. J Clin Epidemiol. 2001;54:495–500.
   PubMed Web of Science ®Google Scholar
• Cooney MT, Vartiainen E, Laatikainen T, et al. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J. 2010;159:612–619.e3.
   PubMed Web of Science ®Google Scholar
• Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 1991;121:172–177.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Jensen GB. Elevated resting heart rate is associated with greater risk of cardiovascular and all-cause mortality in current and former smokers. Int J Cardiol. 2011;151:148–154.
   PubMed Web of Science ®Google Scholar
• Nauman J, Janszky I, Vatten LJ, et al. Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA. 2011;306:2579–2587.
   PubMed Web of Science ®Google Scholar
• Hartaigh BÓ, Gill TM, Shah I, et al. Association between resting heart rate across the life course and all-cause mortality: longitudinal findings from the Medical Research Council (MRC) National Survey of Health and Development (NSHD). J Epidemiol Commun Health. 2014;68:883–889.
   PubMed Web of Science ®Google Scholar
• Palatini P, Casiglia E, Pauletto P, et al. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension. 1997;30:1267–1273.
   PubMed Web of Science ®Google Scholar
• Julius S, Palatini P, Nesbitt SD. Tachycardia: an important determinant of coronary risk in hypertension. J Hypertens Suppl. 1998;16:S9–S15.
   PubMedGoogle Scholar
• Palatini P, Thijs L, Staessen JA, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med. 2002;162:2313–2321.
   PubMed Web of Science ®Google Scholar
• King DE, Everett CJ, Mainous AG, et al. Long-term prognostic value of resting heart rate in subjects with prehypertension. Am J Hypertens. 2006;19:796–800.
   PubMed Web of Science ®Google Scholar
• Palatini P, Dorigatti F, Zaetta V, et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens. 2006;24:1873–1880.
   PubMed Web of Science ®Google Scholar
• Ho JE, Bittner V, Demicco DA, et al. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010;105:905–911.
   PubMed Web of Science ®Google Scholar
• Ó Hartaigh B, Bosch JA, Pilz S, et al. Influence of resting heart rate on mortality in patients undergoing coronary angiography (from the Ludwigshafen Risk and Cardiovascular Health [LURIC] study). Am J Cardiol. 2012;110:515–520.
   PubMed Web of Science ®Google Scholar
• Fox K, Bousser M-G, Amarenco P, et al. Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population. Int J Cardiol. 2013;168:3500–3505.
   PubMed Web of Science ®Google Scholar
• Fox K, Borer JS, Camm JA, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50:823–830.
   PubMed Web of Science ®Google Scholar
• Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3–17.
   PubMed Web of Science ®Google Scholar
• Diaz A, Bourassa MG, Guertin M-C, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967–974.
   PubMed Web of Science ®Google Scholar
• Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–2353.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Messerli FH, Ou F-S, CRUSADE Investigators, et al. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31:552–560.
   PubMed Web of Science ®Google Scholar
• Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol. 1995;48:1197–1205.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Pereira M, Araujo C, et al. Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study. Eur Heart J Acute Cardiovasc Care. 2016;7:149–157.
   Web of Science ®Google Scholar
• Madsen EB, Gilpin E, Henning H, et al. Prediction of late mortality after myocardial infarction from variables measured at different times during hospitalization. Am J Cardiol. 1984;53:47–54.
   PubMed Web of Science ®Google Scholar
• Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65:547–553.
   PubMed Web of Science ®Google Scholar
• Parodi G, Bellandi B, Valenti R, et al. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis. 2010;211:255–259.
   PubMed Web of Science ®Google Scholar
• Bolli R, Fisher DJ, Entman ML. Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. Am Heart J. 1986;111:261–270.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Kaiser C, Sandsten KE, BASKET-PROVE investigators, et al. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes–results from the BASKET PROVE trial. Int J Cardiol. 2013;168:3802–3806.
   PubMed Web of Science ®Google Scholar
• Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J. 2007;28:3012–3019.
   PubMed Web of Science ®Google Scholar
• Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F–49F.
   PubMed Web of Science ®Google Scholar
• Fosbøl EL, Seibaek M, Brendorp B, et al. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study. Int J Cardiol. 2010;140:279–286.
   PubMed Web of Science ®Google Scholar
• McAlister FA, Wiebe N, Ezekowitz JA, et al. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150:784–794.
   PubMed Web of Science ®Google Scholar
• Flannery G, Gehrig-Mills R, Billah B, et al. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol. 2008;101:865–869.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Lange P, et al. Resting heart rate is a predictor of mortality in chronic obstructive pulmonary disease. Eur Respir J. 2012;42:341–349.
   Google Scholar
• Lo SS, Sutton MS, Leslie RD. Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol. 1993;72:305–309.
   PubMed Web of Science ®Google Scholar
• Carnethon MR, Yan L, Greenland P, et al. Resting heart rate in middle age and diabetes development in older age. Diab Care. 2008;31:335–339.
   PubMed Web of Science ®Google Scholar
• Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens. 2009;22:151–155.
   PubMed Web of Science ®Google Scholar
• Gundersen HJ, Neubauer B. A long-term diabetic autonomic nervous abnormality. Reduced variations in resting heart rate measured by a simple and sensitive method. Diabetologia. 1977;13:137–140.
   PubMed Web of Science ®Google Scholar
• Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet Lond Lancet. 1981;1:183–186.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Sogaard P, Andersen HU, et al. Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study. Diabetologia. 2014;57:672–680.
   PubMed Web of Science ®Google Scholar
• Jørgensen PG, Jensen MT, Mogelvang R, et al. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diab Vasc Dis Res. 2016;13:321–330.
   PubMed Web of Science ®Google Scholar
• Lo SS, Leslie RD, Sutton MS. Effects of type 1 diabetes mellitus on cardiac function: a study of monozygotic twins. Br Heart J. 1995;73:450–455.
   PubMedGoogle Scholar
• Hillis GS, Woodward M, Rodgers A, et al. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia. 2012;55:1283–1290.
   PubMed Web of Science ®Google Scholar
• Paterson AD, Rutledge BN, Cleary PA, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, et al. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care. 2007;30:2107–2112.
   PubMed Web of Science ®Google Scholar
• Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci. 2002;47:1716–1722.
   PubMed Web of Science ®Google Scholar
• Koopman FA, Tang MW, Vermeij J, et al. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine. 2016;6:231–237.
   PubMed Web of Science ®Google Scholar
• Jouven X, Escolano S, Celermajer D, et al. Heart rate and risk of cancer death in healthy men. PloS One. 2011;6:e21310.
   PubMed Web of Science ®Google Scholar
• Wannamethee G, Shaper AG, Macfarlane PW. Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases. Am J Epidemiol. 1993;137:735–748.
   PubMed Web of Science ®Google Scholar
• van Kruijsdijk RCM, van der Graaf Y, Bemelmans RHH, SMART Study Group, et al. The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease. Cancer Epidemiol. 2014;38:715–721.
   PubMed Web of Science ®Google Scholar
• Lee DH, Park S, Lim SM, et al. Resting heart rate as a prognostic factor for mortality in patients with breast cancer. Breast Cancer Res Treat. 2016;159:375–384.
   PubMed Web of Science ®Google Scholar
• Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–533.
   PubMed Web of Science ®Google Scholar
• Rehsia NS, Dhalla NS. Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol. 2010;15:e86–e95.
   PubMedGoogle Scholar
• Riganti C, Campia I, Kopecka J, et al. Pleiotropic effects of cardioactive glycosides. Curr Med Chem. 2011;18:872–885.
   PubMed Web of Science ®Google Scholar
• Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-vetricular systolic dysfuntion (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807–816.
   PubMed Web of Science ®Google Scholar
• Fox K, Ford I, Steg PG, BEAUTIFUL investigators, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372:817–821.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875–885.
   PubMed Web of Science ®Google Scholar
• Fox K, Ford I, Steg PG, SIGNIFY Investigators, et al. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371:1091–1099.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Fox KM. The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY. Eur Heart J. 2015;36:2042–2046.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, ESC Scientific Document Group, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
   PubMed Web of Science ®Google Scholar
• Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33:30–42.
   PubMed Web of Science ®Google Scholar
• 2015 Global health care outlook | Deloitte SEA | Life Sciences and Health Care Industry Reports & Services. Deloitte Singap. [cited 2017 Oct 18]. 2015;1–18. Available from: https://www2.deloitte.com/gu/en/pages/life-sciences-and-healthcare/articles/2015-health-care-outlook.html
   Google Scholar
• Janssen I, Katzmarzyk PT, Church TS, et al. The Cooper Clinic Mortality Risk Index: clinical score sheet for men. Am J Prev Med. 2005;29:194–203.
   PubMed Web of Science ®Google Scholar
• Palatini P, Rosei EA, Casiglia E, et al. Management of the hypertensive patient with elevated heart rate: statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens. 2016;34:813–821.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381.
   PubMed Web of Science ®Google Scholar
• Kaiser DW, Harrington RA, Turakhia MP. Wearable fitness trackers and heart disease. JAMA Cardiol. 2016;1:239.
   PubMed Web of Science ®Google Scholar